Emergency ()

Genetic Testing For Hereditary Breast Cancer

Genetic Testing For Hereditary Breast Cancer
in Oncology

Apr 19, 2022

Why is it concerning?

  • An estimated annual incidence of new cases of breast cancer is 1.5 lacs
  • Out of this, 10-12 thousand are hereditary or inherited cancers which are actually preventable cancer.
  • There is increased incidences in younger age groups(<35years)
  • Associated with more aggressive variants like Triple Negative (ER/PR/HER2neu negative)

What are the genes associated with breast cancer?

  • BRCA 1 gene and BRCA 2 gene are associated with hereditary breast cancer and ovarian cancer.

 Who should take this test?

  • Those who have family member with breast, ovarian or peritoneal cancer be evaluated to see, if they have a family history that is associated with an increased risk.
  • GENETIC TESTING SHOULD ONLY BE DONE IN THE SETTING OF PRE AND POST TEST GENETIC COUNSELLING,
  • It should include discussion regarding possible risks and benefits of cancer early detection and prevention modalities.
  • How is the test performed?
  • Test is performed on blood and/or saliva sample.
  • DNA extracted from sample is tested for mutation in specific genes.

What does a positive result imply?

  • BRCA1 or BRCA2 positive implies to an increased risk of developing breast or ovarian cancers.
  • However, a positive test result cannot tell whether or when an individual will actually develop cancer.
  • Both men and women, who inherit a harmful BRCA1or BRCA2 mutation, whether or not they develop cancer themselves, may pass the mutation on to their sons and daughters.

Each child has a 50 percent chance of inheriting a parent’s mutation.

  • Those with positive result should consult doctor immediately for their prevention options.

 What does a negative result imply?

  • Negative result implies to no mutation identified which suggests no increase in cancer risk above general population.

What does an ambiguous or variant of unknown significance (VUS) imply?

  • Sometimes, a genetic test finds a change in BRCA1or BRCA2, that has not been previously associated with cancer-“variant of uncertain significance”(VUS)
  • Because it isn’t known, whether this specific gene change affects a person’s risk of developing cancer.
  • Testing from a lab with strong database might reduce chances of getting an ambiguous result.

What are the prevention options for BRCA positive individuals?

  • Prophylactic surgery(bilateral mastectomy/oopherectomy)
  • Chemoprevention or hormonal therapy
  • Surveillance

Recent Blogs
The Ultimate Guide to Recovery After Breast Cancer Surgery
Being diagnosed with breast cancer is a life-altering experience that requires tremendous strength and resilience. For many women, surgery is often the first major step in their treatment journey.
Continue Reading
Molecular Imaging of Breast Cancer
Continue Reading
Immunotherapy for Pancreatic Cancer
Continue Reading
View all Blogs